India and China are the leading exporters of tranexamic acid, collectively accounting for the majority of global supply, while the United States, Germany, and Japan represent the largest importers by value. These importing nations serve as key distribution hubs for pharmaceutical formulations, with demand closely linked to clinical usage and regulatory approvals. Trade volumes have remained relatively stable over the past three years, with modest growth in imports by emerging markets in Southeast Asia and Latin America, coinciding with gradual adjustments in tranexamic acid prices amid tightening quality compliance requirements.
Tranexamic acid (CAS 1197-18-8) is a white, crystalline, odorless solid at room temperature, with a melting point of approximately 376–380 °C (decomposition). It is a synthetic lysine analog and classified as an organic pharmaceutical compound and amino acid derivative. Primarily used as an active pharmaceutical ingredient (API), it serves in the formulation of antifibrinolytic medications for the management of excessive bleeding. Its principal application is in human pharmaceuticals—including injectables, tablets, and topical preparations—targeting indications such as heavy menstrual bleeding, trauma-related hemorrhage, and surgical blood loss reduction. It is not used as a chemical intermediate in non-pharmaceutical industrial sectors.
Antifibrinolytic agent; blocks lysine binding sites of plasminogen. Hemostatic.
White or almost white, crystalline powder.
This chemical is included in Fine Chemicals. See more about what is Tranexamic acid and Tranexamic acid SDS information.
Find Tranexamic acid supply and Tranexamic acid suppliers on Guidechem to meet your sourcing needs from 431 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.